Literature DB >> 19815557

Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.

Lin Pao-Chun1, Perry M Chan, Wing Chan, Ed Manser.   

Abstract

ACK1 (activated Cdc42-associated kinase 1), a cytoplsmic tyrosine kinase, is implicated in metastatic behavior, cell spreading and migration, and epidermal growth factor receptor (EGFR) signaling. The function of ACK1 in the regulation of receptor tyrosine kinases requires a C-terminal region that demonstrates a significant homology to the EGFR binding domain of MIG6. In this study, we have identified additional receptor tyrosine kinases, including Axl, leukocyte tyrosine kinase, and anaplastic lymphoma kinase, that can bind to the ACK1/MIG6 homology region. Unlike the interaction between MIG6 and EGFR, our data suggest that these receptor tyrosine kinases require the adaptor protein Grb2 for efficient binding, which interacts with highly conserved proline-rich regions that are conserved between ACK1 and MIG6. We have focused on Axl and compared how ACK1/Axl differs from the ACK1/EGFR axis by investigating effects of knockdown of endogenous ACK1. Although EGFR activation promotes ACK1 turnover, Axl activation by GAS6 does not; interestingly, the reciprocal down-regulation of GAS6-stimulated Axl is blocked by removing ACK1. Thus, ACK1 functions in part to control Axl receptor levels. Silencing of ACK1 also leads to diminished ruffling and migration in DU145 and COS7 cells upon GAS6-Axl signaling. The ability of ACK1 to modulate Axl and perhaps anaplastic lymphoma kinase (altered in anaplastic large cell lymphomas) might explain why ACK1 can promote metastatic and transformed behavior in a number of cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815557      PMCID: PMC2787358          DOI: 10.1074/jbc.M109.072660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1.

Authors:  Lee Yeow-Fong; Louis Lim; Ed Manser
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

Review 2.  Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.

Authors:  Sassan Hafizi; Björn Dahlbäck
Journal:  Cytokine Growth Factor Rev       Date:  2006-06-05       Impact factor: 7.638

3.  Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli.

Authors:  Maria L Galisteo; Yan Yang; Jesus Ureña; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

4.  Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.

Authors:  K M Eisenmann; J B McCarthy; M A Simpson; P J Keely; J L Guan; K Tachibana; L Lim; E Manser; L T Furcht; J Iida
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

5.  Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase.

Authors:  O Kranenburg; I Verlaan; W H Moolenaar
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.

Authors:  Nupam P Mahajan; Young E Whang; James L Mohler; H Shelton Earp
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

7.  Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.

Authors:  Feng Shen; Qiong Lin; Yan Gu; Chandra Childress; Wannian Yang
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

8.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Authors:  Edward Htun van der Horst; Yan Y Degenhardt; Astrid Strelow; Anthony Slavin; Lawrence Chinn; Jessica Orf; Minqing Rong; Shyun Li; Lei-Hoon See; Ken Q C Nguyen; Timothy Hoey; Holger Wesche; Scott Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

9.  Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.

Authors:  Katarzyna Modzelewska; Laura P Newman; Radhika Desai; Patricia J Keely
Journal:  J Biol Chem       Date:  2006-10-12       Impact factor: 5.157

10.  Expression of axl in lung adenocarcinoma and correlation with tumor progression.

Authors:  Yi-Shing Shieh; Chiung-Ya Lai; Yu-Rung Kao; Shine-Gwo Shiah; Yi-Wen Chu; Herng-Sheng Lee; Cheng-Wen Wu
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

View more
  21 in total

Review 1.  Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

2.  A pathway map of AXL receptor-mediated signaling network.

Authors:  Shobha Dagamajalu; D A B Rex; Akhina Palollathil; Rohan Shetty; Guruprasad Bhat; Lydia W T Cheung; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-08-23       Impact factor: 5.782

3.  The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase.

Authors:  Ketan S Gajiwala; Neil Grodsky; Ben Bolaños; Junli Feng; RoseAnn Ferre; Sergei Timofeevski; Meirong Xu; Brion W Murray; Ted W Johnson; Al Stewart
Journal:  J Biol Chem       Date:  2017-07-19       Impact factor: 5.157

Review 4.  Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.

Authors:  Pedro Mendez; Jose Luis Ramirez
Journal:  Transl Lung Cancer Res       Date:  2013-04

Review 5.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

6.  Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.

Authors:  Y Liu; M Karaca; Z Zhang; D Gioeli; H S Earp; Y E Whang
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

Review 7.  ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Cancer Lett       Date:  2013-04-15       Impact factor: 8.679

8.  SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.

Authors:  M Buchwald; K Pietschmann; P Brand; A Günther; N P Mahajan; T Heinzel; O H Krämer
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

9.  Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.

Authors:  L Zhou; X-D Liu; M Sun; X Zhang; P German; S Bai; Z Ding; N Tannir; C G Wood; S F Matin; J A Karam; P Tamboli; K Sircar; P Rao; E B Rankin; D A Laird; A G Hoang; C L Walker; A J Giaccia; E Jonasch
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

10.  Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death.

Authors:  Emma Linderoth; Giulia Pilia; Nupam P Mahajan; Ingvar Ferby
Journal:  J Biol Chem       Date:  2013-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.